In the changed post COVID-19 business landscape, the global market for Short-Read Sequencing estimated at US$13. 1 Billion in the year 2020, is projected to reach a revised size of US$25. 3 Billion by 2027, growing at aCAGR of 9.

New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Short-Read Sequencing Industry" - https://www.reportlinker.com/p06032868/?utm_source=GNW
9% over the period 2020-2027. Next-Generation Sequencing, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$16.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sanger Sequencing segment is readjusted to a revised 10.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 9.3% CAGR

The Short-Read Sequencing market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.1% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 32 Featured) -
10x Genomics
Agilent Technologies, Inc.
BGI
Eurofins Scientific
F. Hoffmann-La Roche Ltd
Fasteris
General Electric
Genewiz
GenScript
Illumina, Inc
Macrogen, Inc
Qiagen
Thermo Fisher Scientific, Inc.


Read the full report: https://www.reportlinker.com/p06032868/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Short-Read Sequencing - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Short-Read Sequencing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Short-Read Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2021 & 2027

Table 3: World Recent Past, Current & Future Analysis for
Next-Generation Sequencing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 4: World 7-Year Perspective for Next-Generation
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2021 & 2027

Table 5: World Recent Past, Current & Future Analysis for
Sanger Sequencing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 6: World 7-Year Perspective for Sanger Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Other
End-Uses by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World 7-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 9: World Recent Past, Current & Future Analysis for
Academic Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 10: World 7-Year Perspective for Academic Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 11: World Recent Past, Current & Future Analysis for
Clinical Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 12: World 7-Year Perspective for Clinical Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World 7-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 15: World Recent Past, Current & Future Analysis for
Pharma & Biotech Entities by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 16: World 7-Year Perspective for Pharma & Biotech
Entities by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2021 & 2027

Table 17: World Recent Past, Current & Future Analysis for
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 18: World 7-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World 7-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 21: World Recent Past, Current & Future Analysis for
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 22: World 7-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 23: World Short-Read Sequencing Market Analysis of Annual
Sales in US$ Million for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 24: USA Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 25: USA 7-Year Perspective for Short-Read Sequencing by
Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 26: USA Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 27: USA 7-Year Perspective for Short-Read Sequencing by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 28: USA Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 29: USA 7-Year Perspective for Short-Read Sequencing by
Product - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2021 & 2027

CANADA
Table 30: Canada Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 31: Canada 7-Year Perspective for Short-Read Sequencing
by Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 32: Canada Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 33: Canada 7-Year Perspective for Short-Read Sequencing
by End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 34: Canada Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 35: Canada 7-Year Perspective for Short-Read Sequencing
by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

JAPAN
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 36: Japan Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 37: Japan 7-Year Perspective for Short-Read Sequencing by
Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 38: Japan Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 39: Japan 7-Year Perspective for Short-Read Sequencing by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 40: Japan Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 41: Japan 7-Year Perspective for Short-Read Sequencing by
Product - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2021 & 2027

CHINA
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 42: China Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 43: China 7-Year Perspective for Short-Read Sequencing by
Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 44: China Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 45: China 7-Year Perspective for Short-Read Sequencing by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 46: China Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 47: China 7-Year Perspective for Short-Read Sequencing by
Product - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2021 & 2027

EUROPE
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 48: Europe Recent Past, Current & Future Analysis for
Short-Read Sequencing by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 49: Europe 7-Year Perspective for Short-Read Sequencing
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2021 & 2027

Table 50: Europe Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 51: Europe 7-Year Perspective for Short-Read Sequencing
by Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 52: Europe Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 53: Europe 7-Year Perspective for Short-Read Sequencing
by End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 54: Europe Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 55: Europe 7-Year Perspective for Short-Read Sequencing
by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

FRANCE
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 56: France Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 57: France 7-Year Perspective for Short-Read Sequencing
by Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 58: France Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 59: France 7-Year Perspective for Short-Read Sequencing
by End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 60: France Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 61: France 7-Year Perspective for Short-Read Sequencing
by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

GERMANY
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 62: Germany Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 63: Germany 7-Year Perspective for Short-Read Sequencing
by Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 64: Germany Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 65: Germany 7-Year Perspective for Short-Read Sequencing
by End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 66: Germany Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 67: Germany 7-Year Perspective for Short-Read Sequencing
by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

ITALY
Table 68: Italy Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 69: Italy 7-Year Perspective for Short-Read Sequencing by
Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 70: Italy Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 71: Italy 7-Year Perspective for Short-Read Sequencing by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 72: Italy Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 73: Italy 7-Year Perspective for Short-Read Sequencing by
Product - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2021 & 2027

UNITED KINGDOM
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 74: UK Recent Past, Current & Future Analysis for
Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 75: UK 7-Year Perspective for Short-Read Sequencing by
Technology - Percentage Breakdown of Value Sales for
Next-Generation Sequencing and Sanger Sequencing for the Years
2021 & 2027

Table 76: UK Recent Past, Current & Future Analysis for
Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: UK 7-Year Perspective for Short-Read Sequencing by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 & 2027

Table 78: UK Recent Past, Current & Future Analysis for
Short-Read Sequencing by Product - Consumables, Instruments and
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 79: UK 7-Year Perspective for Short-Read Sequencing by
Product - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2021 & 2027

REST OF EUROPE
Table 80: Rest of Europe Recent Past, Current & Future Analysis
for Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 81: Rest of Europe 7-Year Perspective for Short-Read
Sequencing by Technology - Percentage Breakdown of Value Sales
for Next-Generation Sequencing and Sanger Sequencing for the
Years 2021 & 2027

Table 82: Rest of Europe Recent Past, Current & Future Analysis
for Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 83: Rest of Europe 7-Year Perspective for Short-Read
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Other End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 &
2027

Table 84: Rest of Europe Recent Past, Current & Future Analysis
for Short-Read Sequencing by Product - Consumables, Instruments
and Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 85: Rest of Europe 7-Year Perspective for Short-Read
Sequencing by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

ASIA-PACIFIC
Short-Read Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 86: Asia-Pacific Recent Past, Current & Future Analysis
for Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 87: Asia-Pacific 7-Year Perspective for Short-Read
Sequencing by Technology - Percentage Breakdown of Value Sales
for Next-Generation Sequencing and Sanger Sequencing for the
Years 2021 & 2027

Table 88: Asia-Pacific Recent Past, Current & Future Analysis
for Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 89: Asia-Pacific 7-Year Perspective for Short-Read
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Other End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 &
2027

Table 90: Asia-Pacific Recent Past, Current & Future Analysis
for Short-Read Sequencing by Product - Consumables, Instruments
and Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 91: Asia-Pacific 7-Year Perspective for Short-Read
Sequencing by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

REST OF WORLD
Table 92: Rest of World Recent Past, Current & Future Analysis
for Short-Read Sequencing by Technology - Next-Generation
Sequencing and Sanger Sequencing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 93: Rest of World 7-Year Perspective for Short-Read
Sequencing by Technology - Percentage Breakdown of Value Sales
for Next-Generation Sequencing and Sanger Sequencing for the
Years 2021 & 2027

Table 94: Rest of World Recent Past, Current & Future Analysis
for Short-Read Sequencing by End-Use - Other End-Uses, Academic
Research, Clinical Research, Hospitals & Clinics and Pharma &
Biotech Entities - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 95: Rest of World 7-Year Perspective for Short-Read
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Other End-Uses, Academic Research, Clinical Research, Hospitals &
Clinics and Pharma & Biotech Entities for the Years 2021 &
2027

Table 96: Rest of World Recent Past, Current & Future Analysis
for Short-Read Sequencing by Product - Consumables, Instruments
and Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 97: Rest of World 7-Year Perspective for Short-Read
Sequencing by Product - Percentage Breakdown of Value Sales for
Consumables, Instruments and Services for the Years 2021 & 2027

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032868/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001